... (Thr241Met) polymorphism andlungcancer risk Cancer Epidemiol Biomarkers Prev 2001; 10: 911-2 26 Chen S, Tang D, Xue K, et al DNA repair gene XRCC1 and XPD polymorphisms and risk of lungcancer in a Chinese ... gene XPD and risk of primary lungcancerLungCancer 2002; 36: 15-6 28 Harms C, Salama SA, Sierra-Torres CH, et al Polymorphisms in DNA repair genes, chromosome aberrations, andlungcancer Environ ... polymorphism and risk of primary lungcancer Carcinogenesis 2003; 24: 1677-81 57 Cui Y, Morgenstern H, Greenland S, et al Polymorphism of Xeroderma Pigmentosum group G and the risk of lungcancer and...
... vibrational bands at ∼1,460 and ∼1,400 cm could be ascribed to the in-plane bending vibrations of CH3 On the other hand, the vibrational bands at ∼1,235 and ∼1,085 Characterization of normal andlungcancer ... NCI-H460 lungcancer cells originated from a patient with large cell cancer of the lung (ATCC catalog number: HTB-177), which makes up approximately 10∼20% of lung cancers The NCI-H358 lungcancer ... Infrared spectra of lungcancer cells The infrared spectra of lungcancer cells were recorded as shown in Figs 1b and c It is noteworthy that the νs(PO32) and νs(PO2 ), bands at ∼970 and ∼1,085 cm...
... carcinoma and adenocarcinoma of the lungCancer Res 1994, 54:5652-5 83 Wydner EL, Hoffman D: Smoking andlung cancer: scientific challenges and opportunities Cancer Res 1994, 54:5284-95 84 Engeland ... CYP1A1 exon polymorphism andlungcancer (United States) Cancer Causes Control 2003, 14(4):339-46 Shi X, Zhou S, Wang Z, Zhou Z, Wang Z: CYP1A1 and GSTM1 polymorphisms andlungcancer risk in Chinese ... variants and smoking-related lungcancer in San Francisco Bay area Latinos and African Americans Int J Cancer 2005, 113:141-7 56 Ng DP, Tan KW, Zhao B, Seow A: CYP1A1 polymorphisms and risk of lung cancer...
... randomized pilot trial of lungcancer screening comparing low dose CT scan (LDCT) and chest Xray (CXR) LungCancer 2007, 58:50-58 Bach PB, Silvestri GA, Hanger M, Jett JR: Screening for lung cancer: ... density is given at right, for individuals and group means [NSCCa: non-small cell lung cancer: SCCa: Small cell lung cancer; SqCCa: squamous cell lung cancer; AdCa: Adenocarcinoma; AdBaCa: Adenocarcinoma ... facilitate the non-invasive provision of components of human lung epithelia for epigenetic studies of lungcancerand other lung disease pathogenesis and risk assessment Conclusion Our results suggest...
... Bone Affected by LungCancer The following therapies are used to treat bones affected by lung cancer: • Lungcancer treatment The prompt initiation of appropriate therapy for lungcancer is essential ... percent of people with lungcancer will have their cancer spread, or metastasize, to bone When lungcancer metastasizes, tumor cells from the original cancer break off and travel through the ... INFORMATION ABOUT THE RELATIONSHIP BETWEEN LUNGCANCERAND BONE HEALTH HOW BONE WORKS (PAGE 2) WHAT LUNGCANCER CAN DO TO BONE (PAGE 2) TREATING BONE AFFECTED BY LUNGCANCER (PAGE 3) HYPERCALCEMIA (PAGE...
... 2002 Lungcancer is the most common cause of cancer death for men, who account for 60% of lungcancer cases In women, lungcancer is the second most common cause of cancer death after breast cancer ... for lungcancer are very poor In England, for patients diagnosed between 1993 and 1995 and followed up to 2000, 21.4% of men and 21.8% of women with lungcancer were alive year after diagnosis and ... interventions and supportive and palliative care This section focuses on palliative interventions and supportive and palliative care for patients with lungcancerand therefore only evidence specific to lung...
... PASSIVE SMOKING AND RESPIRATORY SYMPTOMS ANDLUNG FUNCTION IN ADULTS 7.9.1 Recent Studies on Passive Smoking and Adult Respiratory Symptoms andLung Function ... of lungcancer in some large cohort studies among men smoking cigarettes and other types of tobacco 4-15 Age-adjusted lungcancer mortality ratios for males and ... Diagnosis, confirmation, and exclusion of lungcancer cases 5-12 5-5 Estimated relative risk of lungcancer from spousal ETS by epidemiologic study (crude and adjusted for cofactors)...
... epidemiology of lungcancer in Europe LungCancer 2003;41:245–58 Blot WJ, Fraumeni JF Jr Cancers of the lungand pleura In: Schottenfeld D, Fraumeni JF Jr, editors Cancer epidemiology and prevention: ... INTERNATIONAL LUNGCANCER TRENDS programs have been associated with declines in smoking rates and subsequent lungcancer incidence rates.36,37 Renewed cessation and prevention efforts are mandatory ... Janssen-Heijnen ML, Coebergh JW Trends in incidence and prognosis of the histological subtypes of lungcancer in North America, Australia, New Zealand and Europe LungCancer 2001;31:123–37 Janssen-Heijnen...
... U.S railroad workers andlungcancerCancer Causes Control 2006;17(7):911–919 Emmelin A, Nystrom L, Wall S Diesel exhaust exposure and smoking: a case-referent study of lungcancer among Swedish ... exposure–response relationship for diesel exhaust andlungcancer with adjustment for potential confounding from cigarette smoking and other risk factors for lungcancer We conducted a cohort mortality ... subjects and control subjects, and the ability to control for confounding from smoking and other lungcancer risk factors Two main limitations are also apparent First, the data on smoking and other...
... promoter in lungcancer factors that control the use of the p73 P1 promoter and, subsequently, the relative expression of p73 isoforms in lungcancer by using lungcancer cell lines and tumour ... 19) of squamous cell lungcancer samples, and in 50% (13 ⁄ 26) of total lungcancer samples Figure 4C shows TAp73 and Sp1 levels in representative squamous cell carcinoma and adenocarcinoma samples ... TAp73c and Sp1 are co-overexpressed in lungcancer cell lines and tumour samples (A) Western blot analysis of total extracts from 15 lungcancer cell lines revealed coelevation of Sp1 and TAp73c...
... blotting and dot blotting of the analytical density gradients (Figs and 6) Fraction represents the top of the gradient, and fraction 11 is the bottom of the gradient Fractions andand fractions and ... found in fraction (70%) and in fraction (30%) Immunodetection of MRP1 in the absence (B) and in the presence (C) of treatment with MbCD S and R stand for GLC4 (sensitive) and GLC4 ⁄ ADR (resistant) ... glucose Va° and V MbCD are the rates of MRP1-mediated efflux a of PIRA before and after treatment with MbCD, respectively [Chol]° and [Chol]MbCD are the cellular cholesterol contents before and after...
... RDI was ≥ 85% in 59% and 68%, and < 50% in only 5% and 8% of arm A and B patients, respectively Gemcitabine RDI was ≥ 85% in 33% and 74%, and < 50% in 23% and 0% of arm A and B patients, respectively ... Tonato M: Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian LungCancer Project J Clin ... GLF, CM, LC and DA conceived and designed the study LC, CD, GO, EP and CM were responsible for patient care and data acquisition FZ was in charge of quality control and monitoring MDA and ON were...
... histological morphology and immunohistological methods for distinguishing between small cell lungcancer (SCLC) and non-small cell lungcancer (NSCLC) [1] The molecular pathogenesis of lung cancer, as far ... small cell lungcancerand non-small cell lungcancer J Carcinog 2006, 20:4 Kargi A, Gurel D, Tuna B: The diagnostic value of TTF-1, CK 5/ 6, and p63 immunostaining in classification of lung carcinomas ... 2008, 6:69 Background Lungcancer represents a heterogeneous group of diseases in terms of their biology and the clinical course The diagnosis and classification of lung cancers are primarily...
... clinical and laboratory data, data analysis and interpretation, and drafted the manuscript PP and LG participated in acquiring clinical and laboratory data, data analysis and data interpretation and ... surgically and those with advanced disease (stage III and IV) received systemic and/ or local treatment Primary lung tumors were collected after institutional review board approval and handled anonymously ... diagnosis, prognosis and/ or detection of metastatic potential of tumors, including lungcancer As the number of genes methylated in cancer is large and increasing, sensitive and robust multiplexed...
... in cancer pathology Pathology 2007, 39:305-318 Bremnes RM, Veve R, Hirsch FR, Franklin WA: The E-cadherin cell-cell adhesion complex andlungcancer invasion, metastasis, and prognosis LungCancer ... information and final writing of the manuscript VM, SS, PC and EB participated in acquiring clinical and laboratory data, data analysis and data interpretation and drafted the manuscript MP and GVS ... support in facilitating lungcancer specimens and their clinical follow-up Authors’ contributions ML participated in acquiring clinical and laboratory data, data analysis and interpretation, acquiring...
... tissue Figure Cathepsins K, L, and S activity profiles in human lungcancer A) Different stages (I, II, and III) of lungcancerand normal lung tissues were obtained and prepared as described 10 ... Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer Binbin Chen and Manu O Platt* Abstract Background: Cathepsins K, L, and S are cysteine proteases upregulated in cancerand proteolyze ... for each organ and represented by the box and whisker plot For box and whisker plots, the top and bottom of the box represent the 75th and 25th quartile, and whiskers +1.5 SD and -1.5 SD, respectively...
... in cancer pathology Pathology 2007, 39:305-318 Bremnes RM, Veve R, Hirsch FR, Franklin WA: The E-cadherin cell-cell adhesion complex andlungcancer invasion, metastasis, and prognosis LungCancer ... information and final writing of the manuscript VM, SS, PC and EB participated in acquiring clinical and laboratory data, data analysis and data interpretation and drafted the manuscript MP and GVS ... support in facilitating lungcancer specimens and their clinical follow-up Authors’ contributions ML participated in acquiring clinical and laboratory data, data analysis and interpretation, acquiring...
... such as MLD, NTCP and percentage volume of lung receiving more than a threshold dose (Vdose) Hernando [7] reported 201 lungcancer patients treated with 3D conformal radiotherapy, and the rate of ... parameters/NTCP models The total normal lung volume was defined as the total lung volume minus the primary GTV and volume of the trachea and main bronchi From each lung DVH, the following dosimetric ... and so far, this is the only study that looked at concurrent chemotherapy and IMRT [21] More clinical evidence on using IMRT in treating lungcancer is needed We started using IMRT to treat lung...